z-logo
Premium
Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants
Author(s) -
Moreau JeanLuc,
Pieri Lorenzo,
Prud'hon Bernadette
Publication year - 1989
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1989.tb14637.x
Subject(s) - nmda receptor , dextrorphan , pharmacology , dextromethorphan , phencyclidine , flumazenil , diazepam , dizocilpine , chemistry , anticonvulsant , benzodiazepine , triazolam , gabaa receptor , convulsion , clonazepam , anesthesia , medicine , epilepsy , receptor , biochemistry , psychiatry
1 Convulsions were induced reproducibly by intracerebroventricular injection of N‐methyl‐D‐aspartic acid (NMDA) to conscious mice. 2 Competitive (carboxypiperazine‐propylphosphonic acid, CPP; 2‐amino‐7‐phosphonoheptanoic acid, AP7) and non‐competitive (MK801; phencyclidine, PCP; thienylcyclohexylpiperidine, TCP; dextrorphan; dextromethorphan) NMDA antagonists prevented NMDA‐induced convulsions. 3 Benzodiazepine receptor agonists and partial agonists (triazolam, diazepam, clonazepam, Ro 16–6028), classical anticonvulsants (diphenylhydantoin, phenobarbitone, sodium valproate) and meprobamate were also found to prevent NMDA‐induced convulsions. 4 Flumazenil (a benzodiazepine receptor antagonist) and the GABA agonists THIP and muscimol (up to subtoxic doses) were without effect. 5 Flumazenil reversed the anticonvulsant action of diazepam, but not that of MK801. 6 Results obtained in this model differ somewhat from those described in a seizure model with systemic administration of NMDA. An explanation for this discrepancy is offered. 7 This model is a simple test for assessing the in vivo activity of NMDA antagonists and also expands the battery of chemically‐induced seizure models for characterizing anticonvulsants not acting at NMDA receptors.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here